Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02482337 · ClinicalTrials.gov registry record · NA

Per-Oral Endoscopic Myotomy for Esophageal Swallowing Disorders

A NA study, sponsored by Baylor Research Institute.

Terminated
Registry status
NA
Development phase
42
Enrollment target

NCT02482337: Clinical Trial NA study, sponsored by Baylor Research Institute.

NCT02482337 is a NA study that was terminated before completion, run by Baylor Research Institute. The registered enrollment target is 42 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02482337, a NA study, was terminated before completion, sponsored by Baylor Research Institute.

TERMINATED
Registry status
NA
Development phase
42 participants
Enrollment target

Study Summary

The purpose of this study is to show that the Per-Oral Endoscopic Myotomy (POEM) procedure is an effective treatment for people with achalasia.

Primary Outcome

Outcome measure will be assessed by a questionnaire based on the patient's ability to swallow, by radiographic study, upper gastrointestinal endoscopy and ambulatory reflux testing.

Interventions

  • PROCEDURE POEM

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2014-06
Est. Completion 2024-10
Phase NA
Baylor Research Institute

180 total trials

Why NCT02482337 stopped before completion

NCT02482337 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which POEM is the first listed.

NCT02482337 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02482337 about?

NCT02482337 is a clinical study titled "Per-Oral Endoscopic Myotomy for Esophageal Swallowing Disorders". The purpose of this study is to show that the Per-Oral Endoscopic Myotomy (POEM) procedure is an effective treatment for people with achalasia.

What is the current status of trial NCT02482337?

This trial is currently terminated. It is a NA study. The enrollment target is 42 participants. The study started on 2014-06. Estimated completion is 2024-10.

What interventions are being tested in trial NCT02482337?

The interventions under investigation include: POEM (PROCEDURE).

Who is sponsoring clinical trial NCT02482337?

This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02482337's enrollment target sits among peer trials

42 1436th of 2000 higher than 555 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02852213 · 42 participants · Phase 1

    A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients

  • NCT03136146 · 42 participants · Phase 2

    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

  • NCT03178149 · 42 participants · Phase 1

    A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

  • NCT03663530 · 42 participants · NA

    Circadian Misalignment and Energy Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02482337, the US trial registry maintained by the National Library of Medicine. NCT02482337 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.